日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

西妥昔单抗和纳武利尤单抗治疗复发/转移性头颈癌的 II 期临床试验的长期生存率和分子生物标志物评估。

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-2201
Chaudhary Ritu, Moorhead Graydon, Park Robin, Li Jiannong, Schell Michael J, Song Xiaofei, Tan AikChoon, Slebos Robbert J C, Biernacki Maria I, Freeman Samuel S, Thatikonda Sowjanya, Meshkovska Yeva, Hernandez-Prera Juan, Kirtane Kedar, Guevara-Patino Jose A, Amelio Antonio L, Rocco James W, Danysh Brian P, Bonomi Marcelo, Saba Nabil F, Haradhvala Nicholas J, Getz Gad, Chung Christine H
头颈癌
肿瘤
发表日期：2026
文献求助 收藏

Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review

局部复发性头颈癌的挽救治疗：NRG肿瘤工作组综述

期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djag025
Ward, Matthew C; Kang, Jung Julie; Saba, Nabil F; Campbell, Shauna R; Akhave, Neal S; Chang, Steven S; Spencer, Sharon A; Spreafico, Anna; Hanna, Glenn J; Yom, Sue S; Heron, Dwight E
肿瘤
肿瘤免疫
头颈癌
发表日期：2026
文献求助 收藏

A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

一项针对局部晚期头颈部鳞状细胞癌患者的 1 期研究，评估 berzosertib (M6620, VX-970) 与顺铂和放射治疗的疗效 (ETCTN 9950)

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.70346
Bhatia, Aarti; Chen, Zhengjia; Zhang, Yuji; Bruce, Justine Yang; Arnold, Susanne; Kaur, Varinder; Riess, Jonathan W; Fenton, Moon; Burtness, Barbara; Saba, Nabil F; Tara, Harold; Steuer, Conor E; Shin, Dong M; Wasp, Garrett; Davis, Thomas H; Patel, Malini; Schmitz, John C; Bhateja, Priyanka; Diavolitsis, Virginia; Zandberg, Dan P; Mitchell, Darrion L; Kiesel, Brian F; Kunos, Charles; Gore, Steven D; Carducci, Michael; Beumer, Jan H; Owonikoko, Taofeek K
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Quantitative Imaging Advances in HPV-Positive Oropharyngeal Carcinoma

HPV阳性口咽癌定量成像进展

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18020303
Farrell, Dermot; Bahig, Houda; Khor, Richard; Kowalski, Luiz P; de Bree, Remco; Eisbruch, Avraham; Bollen, Heleen; Lopez, Fernando; Sreeram, M P; Guntinas-Lichius, Orlando; Rodrigo, Juan P; Saba, Nabil F; Rao, Karthik N; Nuyts, Sandra; Araújo, Anna Luíza Damaceno; Ferlito, Alfio; Ng, Sweet Ping
肿瘤
口腔癌
肿瘤免疫
发表日期：2026
文献求助 收藏

HPV Detection in Oropharyngeal Cancer: A Narrative Review of Diagnostic and Emerging Molecular Approaches

口咽癌中HPV的检测：诊断和新兴分子方法的叙述性综述

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics16071010
López, Fernando; Bree, Remco de; Sreeram, M P; Nuyts, Sandra; Rodrigo, Juan Pablo; Rao, Karthik N; Saba, Nabil F; Bradford, Carol; Forastiere, Arlene; Kowalski, Luiz P; Araújo, Anna Luíza Damaceno; Suarez, Carlos; Ferlito, Alfio
肿瘤
口腔癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Selection Criteria for De-Escalated Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Based on Prognostic Biomarkers or Early Tumor Response to Therapy: A Narrative Review

基于预后生物标志物或早期肿瘤治疗反应的HPV相关口咽癌降阶梯放化疗选择标准：叙述性综述

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics16050674
Eisbruch, Avraham; Sreeram, M P; Rao, Karthik; Agaimy, Abbas; Kowalski, Luiz P; Pelaz, Andrés Coca; Araújo, Anna Luíza Damaceno; Guntinas-Lichius, Orlando; Rodrigo, Juan P; Lopez, Fernando; Nuyts, Sandra; Saba, Nabil F; Forastiere, Arlene; Bradford, Carol R; Ferlito, Alfio
肿瘤
口腔癌
肿瘤免疫
发表日期：2026
文献求助 收藏

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC

JADE：一项针对局部晚期不可切除头颈部鳞状细胞癌患者的化疗放疗后序贯使用多斯他利单抗的3期研究

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2619653
Siu, Lillian L; Burtness, Barbara; Harrington, Kevin; Psyrri, Amanda; Saba, Nabil F; Tahara, Makoto; Carlson, Gary; Dhar, Arindam; Grimshaw, Matthew; Hua, Lei; Iadevaia, Riham; Theti, Davinder; Vlahovic, Gordana; Machiels, Jean-Pascal
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial

在II期临床试验中，对接受西妥昔单抗和纳武利尤单抗联合治疗的复发和/或转移性头颈部鳞状细胞癌患者的中性粒细胞与淋巴细胞比值进行评估

期刊:American Journal of Clinical Oncology-Cancer Clinical Trials
影响因子:1.8
doi:10.1097/COC.0000000000001255
Park, Robin; Rind, Fahad; Kristoff, Tyler; Li, Jiannong; Schell, Michael; Slebos, Robbert J C; Thatikonda, Sowjanya; Chaudhary, Ritu; Biernacki, Maria I; Meshkovska, Yeva; Kaldas, David; Kim, Hyun-Su; Farinhas, Joaquim; Hernandez-Prera, Juan; Kirtane, Kedar; Hall, MacLean S; Amelio, Antonio L; Rocco, James W; Bhateja, Priyanka; Steuer, Conor; Bonomi, Marcelo; Saba, Nabil F; Chung, Christine H
肿瘤
中性粒细胞
肿瘤免疫
粒细胞
细胞生物学
发表日期：2026
文献求助 收藏

Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot study

阿片类药物和他汀类药物治疗复发/转移性头颈癌患者的生存和疗效：一项探索性试点研究

期刊:Translational Cancer Research
影响因子:1.7
doi:10.21037/tcr-2025-2041
Igbinadolor, Elihu; Kristoff, Tyler J; Shin, Dong M; Steuer, Conor E; Saba, Nabil F; Schmitt, Nicole C
肿瘤
肿瘤免疫
头颈癌
发表日期：2026
文献求助 收藏

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

阿特珠单抗治疗高危局部晚期头颈部鳞状细胞癌：一项随机临床试验

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2025.1483
Haddad, Robert; Fayette, Jérôme; Teixeira, Maria; Prabhash, Kumar; Mesia, Ricard; Kawecki, Andrzej; Dechaphunkul, Arunee; Dinis, José; Guo, Ye; Masuda, Muneyuki; Hsieh, Ching-Yun; Ghi, Maria Grazia; Vaz de Melo Sette, Claudia; Harrington, Kevin; Tahara, Makoto; Saba, Nabil F; Lau, Agnes; Jiang, Tao; Yan, Yibing; Ballinger, Marcus; Kaul, Monika; Matheny, Christina; Cuchelkar, Vaikunth; Wong, Deborah J
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏